References
- StenderupKRosadaCDamTNSalernoEBelinkaBAKachlanySCResolution of psoriasis by a leukocyte-targeting bacterial protein in a humanized mouse modelJ Invest Dermatol20111312033203921654835
- NestleFOKaplanDHBarkerJPsoriasisN Engl J Med200936149650919641206
- GelfandJMDommaschEDShinDBThe risk of stroke in patients with psoriasisJ Invest Dermatol20091292411241819458634
- HoffjanSStemmlerSOn the role of the epidermal differentiation complex in ichthyosis vulgaris, atopic dermatitis and psoriasisBr J Dermatol200715744144917573887
- LowesMABowcockAMKruegerJGPathogenesis and therapy of psoriasisNature200744586687317314973
- SegreJAEpidermal barrier formation and recovery in skin disordersJ Clin Invest20061161150115816670755
- PereraGKDi MeglioPNestleFOPsoriasisAnnu Rev Pathol2012738542222054142
- Di CesareADi MeglioPNestleFOThe IL-23/Th17 axis in the immunopathogenesis of psoriasisJ Invest Dermatol20091291339135019322214
- WangHPetersTKessDActivated macrophages are essential in a murine model for T cell-mediated chronic psoriasiform skin inflammationJ Clin Invest20061162105211416886059
- Rivas BejaranoJJValdecantosWCPsoriasis as autoinflammatory diseaseDermatol Clin20133144546023827247
- RizzoHLKagamiSPhillipsKGKurtzSEJacquesSLBlauveltAIL-23-mediated psoriasis-like epidermal hyperplasia is dependent on IL-17AJ Immunol20111861495150221172868
- CrowJMTherapeutics: Silencing psoriasisNature2012492S58S5923254974
- Dubois DeclercqSPouliotRPromising new treatments for psoriasisScientific World Journal2013201398041923935446
- WongTHsuLLiaoWPhototherapy in psoriasis: a review of mechanisms of actionJ Cutan Med Surg20131761223364144
- Villaseñor-ParkJWheelerDGrandinettiLPsoriasis: evolving treatment for a complex diseaseCleve Clin J Med20127941342322660873
- HanRRostami-YazdiMGerdesSMrowietzUTriptolide in the treatment of psoriasis and other immune-mediated inflammatory diseasesBr J Clin Pharmacol20127442443622348323
- LebwohlMGKavanaughAArmstrongAWVan VoorheesASUS Perspectives in the Management of Psoriasis and Psoriatic Arthritis: Patient and Physician Results from the Population-Based Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) SurveyAm J Clin Dermatol201617879726718712
- KrupkovaOFergusonSJWuertz-KozakKStability of (−)-epigallocatechin gallate and its activity in liquid formulations and delivery systemsJ Nutr Biochem20163711227770867
- BalasubramanianSEckertRLKeratinocyte proliferation, differentiation, and apoptosis–differential mechanisms of regulation by curcumin, EGCG and apigeninToxicol Appl Pharmacol200722421421917493651
- HsuSDickinsonDBorkeJGreen tea polyphenol induces caspase 14 in epidermal keratinocytes via MAPK pathways and reduces psoriasiform lesions in the flaky skin mouse modelExp Dermatol20071667868417620095
- HsuSYamamotoTBorkeJGreen tea polyphenol-induced epidermal keratinocyte differentiation is associated with coordinated expression of p57/KIP2 and caspase 14J Pharmacol Exp Ther200531288489015537824
- BickersDRAtharMNovel approaches to chemoprevention of skin cancerJ Dermatol20002769169511138532
- EllisLZLiuWLuoYGreen tea polyphenol epigallocatechin-3-gallate suppresses melanoma growth by inhibiting inflammasome and IL-1β secretionBiochem Biophys Res Commun201141455155621982776
- KatiyarSKAfaqFPerezAMukhtarHGreen tea polyphenol (−)-epigallocatechin-3-gallate treatment of human skin inhibits ultraviolet radiation-induced oxidative stressCarcinogenesis20012228729411181450
- MeeranSMAkhtarSKatiyarSKInhibition of UVB-induced skin tumor development by drinking green tea polyphenols is mediated through DNA repair and subsequent inhibition of inflammationJ Invest Dermatol20091291258127019020550
- ShankarSChenQSrivastavaRKInhibition of PI3K/AKT and MEK/ERK pathways act synergistically to enhance antiangiogenic effects of EGCG through activation of FOXO transcription factorJ Mol Signal20083718355401
- KhanNBharaliDJAdhamiVMOral administration of naturally occurring chitosan-based nanoformulated green tea polyphenol EGCG effectively inhibits prostate cancer cell growth in a xenograft modelCarcinogenesis20143541542324072771
- SiddiquiIABharaliDJNihalMExcellent anti-proliferative and pro-apoptotic effects of (−)-epigallocatechin-3-gallate encapsulated in chitosan nanoparticles on human melanoma cell growth both in vitro and in vivoNanomedicine2014101619162624965756
- ZhangZTsaiPCRamezanliTMichniak-KohnBBPolymeric nanoparticles-based topical delivery systems for the treatment of dermatological diseasesWiley Interdiscip Rev Nanomed Nanobiotechnol2013520521823386536
- KimDGJeongYIChoiCRetinol-encapsulated low molecular water-soluble chitosan nanoparticlesInt J Pharm200631913013816713152
- SchrandAMSchlagerJJDaiLHussainSMPreparation of cells for assessing ultrastructural localization of nanoparticles with transmission electron microscopyNat Protoc2010574475720360769
- BozzolaJJRussellLDElectron microscopy2nd edSudbury, MAJones & Bartlett1992
- ChamcheuJCPalHCSiddiquiIAProdifferentiation, anti-inflammatory and antiproliferative effects of delphinidin, a dietary anthocyanidin, in a full-thickness three-dimensional reconstituted human skin model of psoriasisSkin Pharmacol Physiol20152817718825620035
- ChamcheuJCChaves-RodriquezMIAdhamiVMUpregulation of PI3K/AKT/mTOR, FABP5 and PPARβ/δ in Human Psoriasis and Imiquimod-induced Murine Psoriasiform Dermatitis ModelActa Derm Venereol20169685485626833029
- ChamcheuJCNavsariaHPihl-LundinILiovicMVahlquistATörmäHChemical chaperones protect epidermolysis bullosa simplex keratinocytes from heat stress-induced keratin aggregation: involvement of heat shock proteins and MAP kinasesJ Invest Dermatol20111311684169121490615
- HuangWHennrickKDrewSA colorful future of quantitative pathology: validation of Vectra technology using chromogenic multiplexed immunohistochemistry and prostate tissue microarraysHum Pathol201344293822944297
- LowesMASuárez-FariñasMKruegerJGImmunology of psoriasisAnnu Rev Immunol20143222725524655295
- MitraARaychaudhuriSKRaychaudhuriSPIL-22 induced cell proliferation is regulated by PI3K/Akt/mTOR signaling cascadeCytokine201260384222840496
- van der FitsLMouritsSVoermanJSImiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axisJ Immunol20091825836584519380832
- ShukuyaRHasegawaTNiwaYOkumaKIkedaSGranulocyte and monocyte adsorption apheresis for generalized pustular psoriasisJ Dermatol2011381130113422007872
- StratisAPasparakisMRupecRAPathogenic role for skin macrophages in a mouse model of keratinocyte-induced psoriasis-like skin inflammationJ Clin Invest20061162094210416886058
- ClarkRAKupperTSMisbehaving macrophages in the pathogenesis of psoriasisJ Clin Invest20061162084208716886055
- ChamcheuJCAdhamiVMEsnaultSDual Inhibition of PI3K/Akt and mTOR by the Dietary Antioxidant, Delphinidin, Ameliorates Psoriatic Features In Vitro and in an Imiquimod-Induced Psoriasis-Like Disease in MiceAntioxid Redox Signal201726496927393705
- WalshDSBorkeJLSinghBBPsoriasis is characterized by altered epidermal expression of caspase 14, a novel regulator of keratinocyte terminal differentiation and barrier formationJ Dermatol Sci200537616315619438
- LippensSKockxMDeneckerGVitamin D3 induces caspase-14 expression in psoriatic lesions and enhances caspase-14 processing in organotypic skin culturesAm J Pathol200416583384115331408
- BrownSJMcLeanWHOne remarkable molecule: filaggrinJ Invest Dermatol201213275176222158554
- SandilandsASutherlandCIrvineADMcLeanWHFilaggrin in the frontline: role in skin barrier function and diseaseJ Cell Sci20091221285129419386895
- KimBEHowellMDGuttman-YasskyETNF-α downregulates filaggrin and loricrin through c-Jun N-terminal kinase: role for TNF-α antagonists to improve skin barrierJ Invest Dermatol20111311272127921346775
- HüffmeierUTraupeHOjiVLoss-of-function variants of the filaggrin gene are not major susceptibility factors for psoriasis vulgaris or psoriatic arthritis in German patientsJ Invest Dermatol20071271367137017255953
- ChamcheuJCSiddiquiIASyedDNAdhamiVMLiovicMMukhtarHKeratin gene mutations in disorders of human skin and its appendagesArch Biochem Biophys201150812313721176769
- CandiESchmidtRMelinoGThe cornified envelope: a model of cell death in the skinNat Rev Mol Cell Biol2005632834015803139
- SchonthalerHBHuggenbergerRWculekSKDetmarMWagnerEFSystemic anti-VEGF treatment strongly reduces skin inflammation in a mouse model of psoriasisProc Natl Acad Sci U S A2009106212642126919995970
- ZenzREferlRKennerLPsoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteinsNature200543736937516163348
- AbramovitsWRivas BejaranoJJValdecantosWCRole of interleukin 1 in atopic dermatitisDermatol Clin20133143744423827246
- KunzeAFörsterUOehrlSSchmitzMSchäkelKAutocrine TNF-α and IL-1β prime 6-sulfo LacNAc+ dendritic cells for high-level production of IL-23Exp Dermatol20172631431627315572
- MabuchiTTakekoshiTHwangSTEpidermal CCR6+ γδ T cells are major producers of IL-22 and IL-17 in a murine model of psoriasiform dermatitisJ Immunol20111875026503121984702
- HedrickMNLonsdorfASShirakawaAKCCR6 is required for IL-23-induced psoriasis-like inflammation in miceJ Clin Invest20091192317232919662682
- SinghBNShankarSSrivastavaRKGreen tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applicationsBiochem Pharmacol2011821807182121827739
- ChakrawartiLAgrawalRDangSGuptaSGabraniRTherapeutic effects of EGCG: a patent reviewExpert Opin Ther Pat20162690791627338088
- GillietMConradCGeigesMPsoriasis triggered by toll-like receptor 7 agonist imiquimod in the presence of dermal plasmacytoid dendritic cell precursorsArch Dermatol20041401490149515611427
- ChamcheuJCSiddiquiIAAdhamiVTopical application of chitosan-based nanoformulated green tea polyphenol EGCG ameliorates imiquimod-induced psoriasis-like skin lesion in miceJ Invest Dermatol2016136S95